drugset / Trial / NCT05472337

Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome

NCT05472337

RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized clinical trial will determine the treatment effect of colchicine (1.5 mg loading dose and 0.5 mg daily thereafter) for 6 weeks on microvascular coronary reperfusion and infarct size in patients with acute coronary syndrome.

Timeline

Start
2022-08-01
Primary completion
2026-03-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.5 mg Oral